Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Gensight Biologics SA banner

Gensight Biologics SA
F:G49N

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
F:G49N
Watchlist
Price: 0.1032 EUR 11.09% Market Closed
Market Cap: €10.7m
Write Note Create Alert Ask AI

Wall St Price Targets

G49N Price Targets Summary
Gensight Biologics SA

Wall Street analysts forecast G49N stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for G49N is 0.419 EUR with a low forecast of 0.2856 EUR and a high forecast of 0.5657 EUR.

G49N Lowest Forecast
Wall Street Target
€0.2856
177% Upside
G49N Average Forecast
Wall Street Target
€0.419
306% Upside
G49N Highest Forecast
Wall Street Target
€0.5657
448% Upside
Lowest Forecast
Price Target
0.2856 EUR
177% Upside
Average Forecast
Price Target
0.419 EUR
306% Upside
Highest Forecast
Price Target
0.5657 EUR
448% Upside
Gensight Biologics SA Competitors:
Price Targets
WINA
Winmark Corp
59% Upside
APA
APA Corp (US)
-3% Downside
AMAL
Amalgamated Bank
10% Upside
INO
Inovio Pharmaceuticals Inc
119% Upside
WINA
Winmark Corp
59% Upside
APA
APA Corp (US)
-3% Downside
AMAL
Amalgamated Bank
10% Upside
INO
Inovio Pharmaceuticals Inc
119% Upside
IBEX
Ibex Ltd
6% Upside
QXO
SilverSun Technologies Inc
109% Upside

Revenue
Forecast

N/A
Past Growth
3 452% / Year
Estimated Growth
Estimates Accuracy
-56%
Average Miss
N/A
Past Growth
3 452% / Year
Estimated Growth
Estimates Accuracy
-56%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 3 452%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

What are analyst estimates?

Continue G49N Research

Summary
G49N intrinsic value, competitors valuation, and company profile.
DCF Valuation
G49N stock valuation using Discount Cash Flow valuation method.
Relative Valuation
G49N stock valuation using valuation multiples.
Wall St Estimates
G49N price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
G49N stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Gensight Biologics SA listings:
OTC • USD
GSGTF
 LSE • EUR
0RIM
 PAR • EUR
SIGHT
 SWB • EUR
G49N
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is G49N's stock price target?
Price Target
0.419 EUR

According to Wall Street analysts, the average 1-year price target for G49N is 0.419 EUR with a low forecast of 0.2856 EUR and a high forecast of 0.5657 EUR.

What is the Revenue forecast for Gensight Biologics SA?
Projected CAGR
3 452%

The compound annual growth rate for Revenue over the next 3 years is 3 452%.

Back to Top
ALPHA SPREAD
Follow us
Join 353,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett